Publications

Safety in infants of SPf66, a synthetic malaria vaccine, delivered alongside the EPI.

SCHELLENBERG, DM; Acosta, CJ; Galindo, CM; Kahigwa, E; Urassa, H; Masanja, H; Aponte, JJ; SCHELLENBERG, JR; Fraser-Hurt, N; Lwilla, F; Menendez, C; Mshinda, H; Tanner, M; Alonso, PL;

2002

Tropical medicine & international health : TM & IH, (2002).4 5 10.1046/j.1365-3156.1999.00424.x.

GAVI, the first steps: lessons for the Global Fund.

Brugha, R; Starling, M; WALT, G;

2002

Lancet, (2002).359 9304 10.1016/S0140-6736(02)07607-9.

Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children.

Alonso, PL; Lopez, MC; Bordmann, G; Smith, TA; Aponte, JJ; Weiss, NA; Urassa, H; Armstrong-Schellenberg, JR; Kitua, AY; Masanja, H; Thomas, MC; Oettli, A; Hurt, N; HAYES, R; Kilama, WL; Tanner, M;

2002

Parasite immunology, (2002).20 2 10.1046/j.1365-3024.1998.00125.x.

The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales.

EDMUNDS, WJ; Brisson, M; Melegaro, A; Gay, NJ;

2002

Vaccine, (2002).20 9-10 10.1016/s0264-410x(01)00473-x.

Patterns of helminth infection and relationship to BCG vaccination in Karonga District, northern Malawi.

Randall, AE; Perez, MA; FLOYD, S; Black, GF; CRAMPIN, AC; Ngwira, B; Pistoni, WN; Mulawa, D; Sichali, L; Mwaungulu, L; BICKLE, Q; FINE, PE M;

2002

Transactions of the Royal Society of Tropical Medicine and Hygiene, (2002).96 1 10.1016/s0035-9203(02)90229-4.

Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E.

Hasan, UA; Harper, DR; WREN, BW; Morrow, WJ W;

2002

Vaccine, (2002).20 9-10 10.1016/s0264-410x(01)00475-3.

The cost-effectiveness of varicella vaccination in Canada.

Brisson, M; EDMUNDS, WJ;

2002

Vaccine, (2002).20 7-8 10.1016/s0264-410x(01)00437-6.

Salmonella vaccines for use in humans: present and future perspectives.

Garmory, HS; Brown, KA; Titball, RW;

2002

FEMS microbiology reviews, (2002).26 4 10.1111/j.1574-6976.2002.tb00619.x.

Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain.

Da Cunha, SS; RODRIGUES, LC; Barreto, ML; Dourado, I;

2002

Vaccine, (2002).20 7-8 10.1016/s0264-410x(01)00438-8.

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis.

Beutels, P; EDMUNDS, WJ; Antoñanzas, F; De Wit, GA; Evans, D; Feilden, R; Fendrick, AM; Ginsberg, GM; Glick, HA; Mast, E; Péchevis, M; Van Doorslaer, EK A; Van Hout, BA; Viral Hepatitis Prevention Board,;

2002

PharmacoEconomics, (2002).20 1 10.2165/00019053-200220010-00001.